EchoGen Emulsion data

A university investigator presented positive results of a Phase III study of EchoGen for use in radiology studies of the liver, kidney and peripheral vascular system. The study, presented at the American Institute of Ultrasound in Medicine meeting in New York, was randomized, double-blind and saline placebo-controlled. Of 253 patients enrolled, 152 received the final formulation and pre-activation technique of EchoGen that will be submitted for FDA review.

Patients underwent a baseline ultrasound exam followed by injections of EchoGen and saline in random sequence. Blinded readers graded the images. ...